This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Aiping Jiang: Innovator in TGF-β Modulation
Introduction
Aiping Jiang is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of transforming growth factor beta (TGF-β) functions. Her work has implications for various therapeutic applications.
Latest Patents
Aiping Jiang holds one patent titled "Methods and compositions for modulation of transforming growth factor beta-regulated functions." This patent discloses compositions and methods for modulating the activity of TGF-β. More specifically, it focuses on the modulation of the release of active TGF-β from an LRRC33-TGF-β prodomain-TGF-β ternary complex. The methods outlined in the patent provide innovative approaches for treatment based on such modulation.
Career Highlights
Aiping Jiang is affiliated with the Children's Medical Center Corporation, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
Aiping has collaborated with esteemed colleagues, including Timothy Alan Springer and Chafen Lu. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Aiping Jiang's contributions to the modulation of TGF-β functions highlight her role as a leading inventor in biotechnology. Her innovative approaches and collaborations continue to pave the way for advancements in medical treatments.